Disclosures for "Medication Adherence and Cost of Care for Comorbid Conditions in Patients with Early Alzheimer's Disease: A Retrospective Cohort Study Using the Axon Registry and Claims Data"
-
Dr. Lv has received personal compensation for serving as an employee of Novo Nordisk .
-
Dr. Aly has received personal compensation for serving as an employee of Novo Nordisk Incorporated. Dr. Aly has stock in Novo Nordisk Incorporated.
-
Dr. McKay has received personal compensation for serving as an employee of Novo Nordisk. Dr. McKay has stock in Novo Nordisk. Dr. McKay has stock in Takeda. Dr. McKay has stock in Johnson & Johnson. Dr. McKay has stock in Merck.
-
Dr. Mystkowski has received personal compensation for serving as an employee of Novo Nordisk. Dr. Mystkowski has stock in Novo Nordisk.
-
Ms. Gallagher has received personal compensation for serving as an employee of Verana Health.
-
Mr. Garcia has received personal compensation for serving as an employee of Verana Health.
-
Dr. Moss has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Verana Health. Dr. Moss has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Legal Firms. The institution of Dr. Moss has received research support from NIH. The institution of Dr. Moss has received research support from Research to Prevent Blindness. Dr. Moss has received intellectual property interests from a discovery or technology relating to health care. Dr. Moss has received personal compensation in the range of $0-$499 for serving as a grant review panel with National Institutes of Health. Dr. Moss has a non-compensated relationship as a Board of Directors with North American Neuro-ophthalmology Society that is relevant to AAN interests or activities.
-
Dr. Mattke has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Mattke has received personal compensation in the range of $500-$4,999 for serving as a Consultant for C2N. Dr. Mattke has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novo Nordisk. Dr. Mattke has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Senscio Systems. The institution of Dr. Mattke has received research support from various companies, CMS.